Cases 31 - 40 of 11,549
Norwich Pharmaceuticals, Inc. v. Xavier Becerra, et al
as 23-5311
Plaintiff:
Norwich Pharmaceuticals, Inc.
Defendant:
Xavier Becerra, in his official capacity as Secretary of Health and Human Services, Robert McKinnon Califf, M.D., in his official capacity as Commissioner of Food and Drugs and United States Food and Drug Administration
Intervenor:
Salix Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. v. Samsung Bioepis Co., Ltd.
as WVN/1:23-CV-00106
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Defendant:
Samsung Bioepis Co., Ltd.
Miller Rich v. Altum Pharmaceuticals Inc.
as 23-8101
Plaintiff / Appellant:
NANCY MILLERRICH
Defendant / Appellee:
ALTUM PHARMACEUTICALS INC., BETTERLIFE PHARMA INC., AHMAD DOROUDIAN and others
Defendant:
JOHN AND JANE DOES 150, ABC CORPORATIONS 120, KRISZTIAN TOTH and others
AZURITY PHARMACEUTICALS, INC. v. NOVITIUM PHARMA, LLC
as 3:2023cv23315
Plaintiff:
AZURITY PHARMACEUTICALS, INC.
Defendant:
NOVITIUM PHARMA, LLC
Cause Of Action: 15 U.S.C. § 15 Antitrust Litigation
Blue Cross and Blue Shield of Florida Inc. et al v. Jazz Pharmaceuticals Inc. et al
as 3:2023cv01453
Plaintiff:
Blue Cross and Blue Shield of Florida Inc. and Health Options Inc.
Defendant:
Jazz Pharmaceuticals Inc., Jazz Pharmaceuticals Ireland Limited, JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY and others
Cause Of Action: 28 U.S.C. § 1337 Sherman-Clayton Act
MILLER v. EAGLE PHARMACEUTICALS, INC. et al
as 2:2023cv23011
Plaintiff:
NICHOLAS MILLER
Defendant:
EAGLE PHARMACEUTICALS, INC., SCOTT TARIFF and BRIAN CAHILL
Cause Of Action: 28 U.S.C. § 1331 Fed. Question: Securities Violation
Regeneron Pharmaceuticals, Inc. v. Formycon AG
as WVN/1:23-CV-00097
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Defendant:
Formycon AG
Regeneron Pharmaceuticals, Inc. v. Samsung Bioepis, CO., LTD.,
as WVN/1:23-CV-00094
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Defendant:
Samsung Bioepis, CO., LTD., and Samsung Bioepis Co., Ltd.
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc.
as WVN/1:23-CV-00089
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Defendant:
Celltrion, Inc.
Ascent Pharmaceuticals, Inc. v. Garland et al
as 2:2023cv08260
Plaintiff:
Ascent Pharmaceuticals, Inc.
Defendant:
Merrick B. Garland, United States Department of Justice, United States Drug Enforcement Administration and others
Cause Of Action: 28 U.S.C. § 2201 Declaratory Judgement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
